Trial intelligence / Profile preview

Chloroquine vs Amodiaquine for Malaria in Children

NCT00137514Phase 4Completed

Sponsor
Bandim Health Project
Start
Mar 2001
Primary completion
May 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of amodiaquine and chloroquine in Falciparum malaria (PF) (4 arms), sponsored by Bandim Health Project. Primary endpoints: Parasite reappearance rate at Day 35 and Hospitalization during follow-up at Day 35. Started Mar 2001; status: completed.

02

Drugs

amodiaquinechloroquine
03

Conditions

Falciparum malaria (PF)

Beyond the preview

Go deeper on NCT00137514.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00137514.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call